GAS5 and nasopharyngeal carcinoma: Moreover, two GAS5 SNPs, which included rs2067079 and rs6790, were associated with a higher possibility of toxic reaction after platinum-based concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma [43].